| 2.4 |
7.1 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 2.3 |
6.8 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 2.0 |
8.0 |
GO:0097393 |
post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) |
| 1.9 |
5.6 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 1.7 |
6.6 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 1.3 |
6.6 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 1.3 |
5.2 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 1.3 |
6.4 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 1.3 |
1.3 |
GO:0034183 |
negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
| 1.0 |
10.1 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 1.0 |
6.1 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 1.0 |
3.0 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 1.0 |
10.0 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 1.0 |
6.9 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 1.0 |
3.9 |
GO:0072362 |
regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072362) |
| 1.0 |
3.9 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
| 1.0 |
2.9 |
GO:1990481 |
snoRNA guided rRNA pseudouridine synthesis(GO:0000454) snRNA pseudouridine synthesis(GO:0031120) mRNA pseudouridine synthesis(GO:1990481) |
| 1.0 |
2.9 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 1.0 |
4.8 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 0.9 |
3.8 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.9 |
2.7 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.9 |
6.3 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.9 |
5.2 |
GO:0072393 |
microtubule anchoring at microtubule organizing center(GO:0072393) |
| 0.9 |
4.3 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.8 |
2.5 |
GO:0061535 |
glutamate secretion, neurotransmission(GO:0061535) |
| 0.8 |
2.5 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.8 |
2.5 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.8 |
3.3 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.8 |
4.1 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.8 |
2.3 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.7 |
6.3 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.7 |
2.1 |
GO:1902037 |
negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.7 |
2.7 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.7 |
5.3 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.7 |
2.0 |
GO:1901254 |
positive regulation of intracellular transport of viral material(GO:1901254) |
| 0.7 |
3.9 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.6 |
4.5 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.6 |
1.9 |
GO:0032916 |
positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 0.6 |
1.8 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.6 |
1.8 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.6 |
2.4 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.6 |
1.7 |
GO:0032240 |
RNA import into nucleus(GO:0006404) mRNA export from nucleus in response to heat stress(GO:0031990) negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.6 |
2.9 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.6 |
2.9 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.6 |
2.3 |
GO:2001274 |
negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.6 |
3.4 |
GO:0051660 |
cortical microtubule organization(GO:0043622) establishment of centrosome localization(GO:0051660) |
| 0.6 |
5.7 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.6 |
4.5 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.6 |
2.2 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 0.6 |
1.7 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.5 |
2.7 |
GO:1905049 |
negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
| 0.5 |
3.2 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.5 |
2.6 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.5 |
1.5 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.5 |
4.1 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.5 |
2.5 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.5 |
2.5 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 0.5 |
1.5 |
GO:0031590 |
wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
| 0.5 |
2.0 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.5 |
9.9 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.5 |
1.5 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.5 |
2.0 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 0.5 |
2.4 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.5 |
1.4 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.5 |
1.4 |
GO:2000314 |
negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.5 |
2.8 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.5 |
1.8 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.4 |
5.8 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.4 |
3.1 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.4 |
1.3 |
GO:0060489 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.4 |
1.3 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.4 |
0.9 |
GO:0060853 |
arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel endothelial cell fate specification(GO:0097101) |
| 0.4 |
6.9 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.4 |
1.3 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.4 |
1.7 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.4 |
1.2 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) protein K29-linked ubiquitination(GO:0035519) |
| 0.4 |
1.2 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.4 |
1.2 |
GO:0043323 |
positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.4 |
1.2 |
GO:0031627 |
telomeric loop formation(GO:0031627) |
| 0.4 |
1.2 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.4 |
1.2 |
GO:0043379 |
memory T cell differentiation(GO:0043379) |
| 0.4 |
1.9 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.4 |
0.4 |
GO:0032910 |
transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
| 0.4 |
1.9 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.4 |
1.5 |
GO:2001045 |
closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.4 |
5.7 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.4 |
1.9 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.4 |
1.5 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.4 |
4.9 |
GO:0036120 |
cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.4 |
2.9 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.4 |
2.6 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.4 |
2.2 |
GO:0021631 |
optic nerve morphogenesis(GO:0021631) |
| 0.4 |
0.7 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.4 |
0.7 |
GO:0060745 |
mammary gland branching involved in pregnancy(GO:0060745) |
| 0.3 |
0.7 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.3 |
7.0 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.3 |
4.6 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.3 |
1.0 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.3 |
1.6 |
GO:0010835 |
regulation of protein ADP-ribosylation(GO:0010835) |
| 0.3 |
1.0 |
GO:0070103 |
interleukin-4-mediated signaling pathway(GO:0035771) tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) regulation of interleukin-6-mediated signaling pathway(GO:0070103) negative regulation of interleukin-6-mediated signaling pathway(GO:0070104) |
| 0.3 |
0.9 |
GO:0030862 |
regulation of polarized epithelial cell differentiation(GO:0030860) positive regulation of polarized epithelial cell differentiation(GO:0030862) |
| 0.3 |
0.9 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.3 |
0.9 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.3 |
0.9 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.3 |
3.7 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.3 |
1.5 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.3 |
0.9 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.3 |
1.8 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.3 |
2.7 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.3 |
1.2 |
GO:0070425 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 0.3 |
2.4 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.3 |
1.8 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.3 |
1.2 |
GO:0019042 |
viral latency(GO:0019042) |
| 0.3 |
3.4 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
| 0.3 |
1.4 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.3 |
0.8 |
GO:0060729 |
preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) intestinal epithelial structure maintenance(GO:0060729) |
| 0.3 |
1.1 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.3 |
0.6 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.3 |
0.8 |
GO:0008594 |
photoreceptor cell morphogenesis(GO:0008594) |
| 0.3 |
2.2 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.3 |
3.2 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.3 |
1.6 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.3 |
2.9 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.3 |
5.0 |
GO:0031442 |
positive regulation of mRNA 3'-end processing(GO:0031442) |
| 0.3 |
1.0 |
GO:0048341 |
paraxial mesoderm formation(GO:0048341) |
| 0.3 |
1.0 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.3 |
1.5 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
| 0.3 |
4.6 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.3 |
2.5 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.3 |
2.8 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.2 |
3.0 |
GO:0000059 |
protein import into nucleus, docking(GO:0000059) |
| 0.2 |
1.0 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.2 |
0.7 |
GO:2000675 |
negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.2 |
1.2 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 0.2 |
0.7 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.2 |
1.4 |
GO:0035372 |
protein localization to microtubule(GO:0035372) mitotic cytokinetic process(GO:1902410) |
| 0.2 |
0.7 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.2 |
2.1 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.2 |
1.8 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.2 |
0.7 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.2 |
0.5 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.2 |
1.1 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.2 |
4.2 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.2 |
1.3 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.2 |
0.7 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.2 |
5.7 |
GO:0043153 |
entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.2 |
1.7 |
GO:1902065 |
response to L-glutamate(GO:1902065) |
| 0.2 |
2.6 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.2 |
0.6 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.2 |
1.1 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.2 |
1.3 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
| 0.2 |
1.9 |
GO:0090169 |
regulation of spindle assembly(GO:0090169) |
| 0.2 |
1.9 |
GO:0048570 |
notochord morphogenesis(GO:0048570) |
| 0.2 |
2.3 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.2 |
3.9 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.2 |
3.9 |
GO:0048520 |
positive regulation of behavior(GO:0048520) |
| 0.2 |
4.9 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.2 |
1.4 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.2 |
4.5 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.2 |
2.6 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.2 |
0.6 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.2 |
1.4 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.2 |
0.6 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.2 |
5.3 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.2 |
2.5 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.2 |
2.6 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.2 |
0.7 |
GO:0043974 |
histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 0.2 |
1.3 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.2 |
1.7 |
GO:1901409 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.2 |
2.0 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.2 |
4.3 |
GO:0044783 |
mitotic G1 DNA damage checkpoint(GO:0031571) G1 DNA damage checkpoint(GO:0044783) |
| 0.2 |
1.1 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 0.2 |
2.2 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.2 |
1.1 |
GO:0060008 |
Sertoli cell differentiation(GO:0060008) |
| 0.2 |
0.7 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.2 |
2.5 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.2 |
0.4 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.2 |
1.9 |
GO:2000780 |
negative regulation of double-strand break repair(GO:2000780) |
| 0.2 |
2.6 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.2 |
1.0 |
GO:0051461 |
regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.2 |
0.7 |
GO:0043619 |
regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
| 0.2 |
1.7 |
GO:2000637 |
positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.2 |
0.5 |
GO:0000710 |
meiotic mismatch repair(GO:0000710) |
| 0.2 |
1.1 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.2 |
1.1 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.2 |
1.4 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.2 |
0.3 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.2 |
0.8 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.2 |
0.9 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.2 |
2.0 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.2 |
1.7 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.2 |
0.5 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.2 |
0.6 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.2 |
0.2 |
GO:0071105 |
response to interleukin-11(GO:0071105) |
| 0.2 |
1.2 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.2 |
1.5 |
GO:0060693 |
regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.2 |
0.6 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 |
1.0 |
GO:0046477 |
glycosylceramide catabolic process(GO:0046477) |
| 0.1 |
1.3 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.1 |
2.1 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.1 |
0.7 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.1 |
3.5 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.1 |
0.4 |
GO:0070625 |
zymogen granule exocytosis(GO:0070625) |
| 0.1 |
1.5 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.1 |
0.9 |
GO:0048549 |
positive regulation of pinocytosis(GO:0048549) |
| 0.1 |
0.3 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.1 |
1.3 |
GO:0061669 |
spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.1 |
0.9 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
0.4 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 |
0.8 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
0.7 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.1 |
1.5 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.1 |
0.6 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.1 |
1.7 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 |
1.5 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.1 |
1.6 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.1 |
1.5 |
GO:0000394 |
RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 |
0.3 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.1 |
1.8 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
| 0.1 |
1.7 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.1 |
0.7 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) response to pheromone(GO:0019236) |
| 0.1 |
0.8 |
GO:0042795 |
snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.1 |
0.4 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.1 |
0.8 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 |
1.0 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.1 |
1.0 |
GO:0033182 |
regulation of histone ubiquitination(GO:0033182) positive regulation of histone ubiquitination(GO:0033184) |
| 0.1 |
1.5 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 |
1.4 |
GO:0071549 |
response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
| 0.1 |
0.6 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.1 |
1.2 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.1 |
1.5 |
GO:0060746 |
parental behavior(GO:0060746) |
| 0.1 |
4.7 |
GO:0017145 |
stem cell division(GO:0017145) |
| 0.1 |
0.9 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.1 |
0.1 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.1 |
0.2 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) |
| 0.1 |
0.9 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 0.1 |
1.1 |
GO:0055090 |
acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.1 |
0.5 |
GO:0006867 |
asparagine transport(GO:0006867) glutamine transport(GO:0006868) |
| 0.1 |
1.2 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 |
0.9 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.1 |
0.6 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.1 |
2.5 |
GO:0006359 |
regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.1 |
0.3 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 0.1 |
1.4 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.1 |
0.1 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.1 |
1.8 |
GO:0046325 |
negative regulation of glucose import(GO:0046325) |
| 0.1 |
0.7 |
GO:2000973 |
regulation of pro-B cell differentiation(GO:2000973) |
| 0.1 |
2.5 |
GO:0044030 |
regulation of DNA methylation(GO:0044030) |
| 0.1 |
0.9 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.1 |
1.4 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.1 |
1.1 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.1 |
0.5 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.1 |
0.5 |
GO:0051189 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.1 |
0.8 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.1 |
5.6 |
GO:0045638 |
negative regulation of myeloid cell differentiation(GO:0045638) |
| 0.1 |
0.3 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) synaptic vesicle lumen acidification(GO:0097401) |
| 0.1 |
1.9 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 |
4.2 |
GO:0007492 |
endoderm development(GO:0007492) |
| 0.1 |
1.7 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.1 |
0.4 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.1 |
1.3 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 |
1.3 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 0.1 |
0.6 |
GO:0070989 |
oxidative demethylation(GO:0070989) |
| 0.1 |
1.3 |
GO:0034724 |
DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.1 |
3.9 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.1 |
3.8 |
GO:0007032 |
endosome organization(GO:0007032) |
| 0.1 |
2.3 |
GO:0010955 |
negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
| 0.1 |
1.0 |
GO:0051561 |
positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.1 |
1.1 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.1 |
0.5 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 |
0.8 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 |
0.8 |
GO:0002920 |
regulation of humoral immune response(GO:0002920) |
| 0.1 |
1.1 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.1 |
1.3 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.1 |
0.4 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.1 |
0.5 |
GO:1903912 |
regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
| 0.1 |
0.8 |
GO:0036371 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 0.1 |
1.3 |
GO:0010640 |
regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
| 0.1 |
0.3 |
GO:0002586 |
regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.1 |
0.3 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.1 |
0.5 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.1 |
0.4 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.1 |
2.2 |
GO:0032355 |
response to estradiol(GO:0032355) |
| 0.1 |
0.5 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.1 |
1.5 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.1 |
1.3 |
GO:0071897 |
DNA biosynthetic process(GO:0071897) |
| 0.1 |
1.0 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 |
0.4 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.1 |
0.2 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 0.1 |
0.2 |
GO:0061038 |
uterus morphogenesis(GO:0061038) |
| 0.1 |
2.6 |
GO:0042491 |
auditory receptor cell differentiation(GO:0042491) |
| 0.1 |
2.9 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.1 |
1.7 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.1 |
1.4 |
GO:0035909 |
aorta morphogenesis(GO:0035909) |
| 0.1 |
1.2 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.1 |
0.3 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.1 |
0.3 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.1 |
0.4 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.1 |
0.4 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.1 |
0.5 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.1 |
0.6 |
GO:2000758 |
positive regulation of histone acetylation(GO:0035066) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
| 0.1 |
0.5 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.1 |
2.7 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.1 |
1.0 |
GO:0007289 |
spermatid nucleus differentiation(GO:0007289) |
| 0.1 |
0.5 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.1 |
0.2 |
GO:2000304 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.1 |
0.3 |
GO:0007128 |
meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
| 0.1 |
0.8 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.1 |
1.5 |
GO:0031116 |
positive regulation of microtubule polymerization(GO:0031116) |
| 0.1 |
1.2 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.1 |
0.4 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.1 |
0.2 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.1 |
0.2 |
GO:0048611 |
ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 0.1 |
0.3 |
GO:1900864 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.1 |
0.6 |
GO:0007176 |
regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.1 |
0.2 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.1 |
0.7 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.1 |
3.4 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.1 |
0.8 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.1 |
0.6 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.1 |
1.1 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 |
0.2 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.1 |
2.0 |
GO:0086010 |
membrane depolarization during action potential(GO:0086010) |
| 0.1 |
1.2 |
GO:0003170 |
heart valve development(GO:0003170) |
| 0.1 |
0.6 |
GO:0033572 |
transferrin transport(GO:0033572) |
| 0.1 |
0.2 |
GO:0001865 |
NK T cell differentiation(GO:0001865) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
| 0.1 |
1.5 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.1 |
0.1 |
GO:0035622 |
intrahepatic bile duct development(GO:0035622) |
| 0.1 |
0.5 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 0.1 |
1.2 |
GO:0030335 |
positive regulation of cell migration(GO:0030335) |
| 0.1 |
0.2 |
GO:1900060 |
negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.1 |
0.2 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.0 |
1.1 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.0 |
0.4 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.0 |
0.4 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.0 |
1.3 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.0 |
1.2 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
0.4 |
GO:0000479 |
endonucleolytic cleavage involved in rRNA processing(GO:0000478) endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.0 |
0.5 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.0 |
1.9 |
GO:0051897 |
positive regulation of protein kinase B signaling(GO:0051897) |
| 0.0 |
0.2 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.0 |
0.1 |
GO:0046984 |
very-low-density lipoprotein particle assembly(GO:0034379) regulation of hemoglobin biosynthetic process(GO:0046984) |
| 0.0 |
0.4 |
GO:0002098 |
tRNA wobble uridine modification(GO:0002098) |
| 0.0 |
0.2 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) mitochondrial protein processing(GO:0034982) |
| 0.0 |
0.5 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 |
1.3 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.0 |
0.2 |
GO:0071267 |
amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
| 0.0 |
0.2 |
GO:0032367 |
intracellular cholesterol transport(GO:0032367) |
| 0.0 |
0.4 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.0 |
0.5 |
GO:0051895 |
negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) |
| 0.0 |
0.7 |
GO:0001779 |
natural killer cell differentiation(GO:0001779) |
| 0.0 |
0.2 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.0 |
0.4 |
GO:0051642 |
centrosome localization(GO:0051642) |
| 0.0 |
0.8 |
GO:0005978 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.0 |
1.3 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.0 |
0.4 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 0.0 |
0.3 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.0 |
0.7 |
GO:0061025 |
membrane fusion(GO:0061025) |
| 0.0 |
0.3 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.0 |
0.1 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.0 |
0.2 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.0 |
0.2 |
GO:0021960 |
anterior commissure morphogenesis(GO:0021960) |
| 0.0 |
0.3 |
GO:0043967 |
histone H4 acetylation(GO:0043967) |
| 0.0 |
1.4 |
GO:0002224 |
toll-like receptor signaling pathway(GO:0002224) |
| 0.0 |
0.3 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.0 |
0.9 |
GO:0008045 |
motor neuron axon guidance(GO:0008045) |
| 0.0 |
2.5 |
GO:0006275 |
regulation of DNA replication(GO:0006275) |
| 0.0 |
0.2 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.0 |
0.7 |
GO:0043392 |
negative regulation of DNA binding(GO:0043392) |
| 0.0 |
1.6 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 |
0.5 |
GO:0007031 |
peroxisome organization(GO:0007031) |
| 0.0 |
2.8 |
GO:0002244 |
hematopoietic progenitor cell differentiation(GO:0002244) |
| 0.0 |
0.2 |
GO:0060632 |
regulation of microtubule-based movement(GO:0060632) |
| 0.0 |
1.4 |
GO:0016573 |
histone acetylation(GO:0016573) |
| 0.0 |
0.1 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.0 |
0.2 |
GO:0072673 |
lamellipodium morphogenesis(GO:0072673) |
| 0.0 |
0.6 |
GO:0032801 |
receptor catabolic process(GO:0032801) |
| 0.0 |
0.3 |
GO:0022617 |
extracellular matrix disassembly(GO:0022617) |
| 0.0 |
1.2 |
GO:0007029 |
endoplasmic reticulum organization(GO:0007029) |
| 0.0 |
0.3 |
GO:0048714 |
positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.0 |
0.6 |
GO:0046579 |
positive regulation of Ras protein signal transduction(GO:0046579) |
| 0.0 |
0.1 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.0 |
3.7 |
GO:0018108 |
peptidyl-tyrosine phosphorylation(GO:0018108) |
| 0.0 |
0.5 |
GO:0016233 |
telomere capping(GO:0016233) |
| 0.0 |
0.8 |
GO:0042035 |
regulation of cytokine biosynthetic process(GO:0042035) |
| 0.0 |
0.1 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 |
0.1 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.0 |
1.7 |
GO:0048706 |
embryonic skeletal system development(GO:0048706) |
| 0.0 |
0.3 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.0 |
0.7 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.6 |
GO:1900271 |
regulation of long-term synaptic potentiation(GO:1900271) |
| 0.0 |
0.2 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.0 |
0.3 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.0 |
0.2 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.0 |
0.1 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.0 |
0.3 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.0 |
0.1 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.0 |
0.2 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.0 |
0.5 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
| 0.0 |
0.4 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.0 |
0.1 |
GO:0045006 |
DNA deamination(GO:0045006) |
| 0.0 |
0.1 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.0 |
1.1 |
GO:0030509 |
BMP signaling pathway(GO:0030509) |
| 0.0 |
0.4 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 |
0.2 |
GO:0030836 |
positive regulation of actin filament depolymerization(GO:0030836) |
| 0.0 |
0.3 |
GO:0070373 |
negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.0 |
0.3 |
GO:0045668 |
negative regulation of osteoblast differentiation(GO:0045668) |
| 0.0 |
0.1 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.0 |
0.4 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.0 |
0.3 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.0 |
0.2 |
GO:0099500 |
synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.0 |
0.4 |
GO:0007498 |
mesoderm development(GO:0007498) |
| 0.0 |
0.2 |
GO:0072600 |
establishment of protein localization to Golgi(GO:0072600) |
| 0.0 |
0.3 |
GO:0071479 |
cellular response to ionizing radiation(GO:0071479) |
| 0.0 |
0.2 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.0 |
0.8 |
GO:0051321 |
meiotic cell cycle(GO:0051321) |
| 0.0 |
0.0 |
GO:0051292 |
pore complex assembly(GO:0046931) nuclear pore complex assembly(GO:0051292) |
| 0.0 |
0.0 |
GO:0034382 |
chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.0 |
0.4 |
GO:0000725 |
double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.0 |
0.2 |
GO:0035082 |
axoneme assembly(GO:0035082) |
| 0.0 |
0.1 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.0 |
0.1 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 |
0.1 |
GO:0009409 |
response to cold(GO:0009409) |
| 0.0 |
0.0 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
